TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Leo Pharma AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
153,555
|
157,865
|
173,369 |
| Financial expenses |
3,819
|
2,324
|
418 |
| Earnings before taxes |
4,198
|
6,195
|
7,824 |
| EBITDA |
5,925
|
6,546
|
8,302 |
| Total assets |
101,174
|
132,245
|
208,845 |
| Current assets |
94,924
|
124,311
|
193,707 |
| Current liabilities |
59,600
|
81,858
|
97,831 |
| Equity capital |
32,923
|
29,813
|
25,482 |
| - share capital |
1,000
|
1,000
|
1,000 |
| Employees (average) |
23
|
18
|
31 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
32.5%
|
22.5%
|
12.2% |
| Turnover per employee |
6,676
|
8,770
|
5,593 |
| Profit as a percentage of turnover |
2.7%
|
3.9%
|
4.5% |
| Return on assets (ROA) |
7.9%
|
6.4%
|
3.9% |
| Current ratio |
159.3%
|
151.9%
|
198.0% |
| Return on equity (ROE) |
12.8%
|
20.8%
|
30.7% |
| Change turnover |
-4,310
|
-15,504
|
-14,865 |
| Change turnover % |
-3%
|
-9%
|
-8% |
| Chg. No. of employees |
5
|
-13
|
-4 |
| Chg. No. of employees % |
28%
|
-42%
|
-11% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.